Iris Morphologic Changes Related to α1-Adrenergic Receptor Antagonists. Implications for Intraoperative Floppy Iris Syndrome

Tiago Santos Prata, Pat Michael Palmiero, Allison Angelilli, Zaher Sbeity, Carlos Gustavo V. De Moraes, Jeffrey M. Liebmann, Robert Ritch

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Abstract

Purpose: To identify iris structural alterations associated with intraoperative floppy iris syndrome (IFIS) in patients using systemic α1-adrenergic receptor antagonists (α-1ARA). Design: Cross-sectional study. Participants and Controls: Twenty-nine patients with current or past treatment with any systemic α-1ARA and 22 untreated controls. Methods: Consecutive eligible patients underwent slit-lamp-adapted optical coherence tomography in a masked fashion under standardized lighting conditions. Main Outcome Measures: Iris thickness at the dilator muscle region (DMR; measured at half of the distance between the scleral spur and the pupillary margin) and at the sphincter muscle region (SMR; 0.75 mm from the pupillary margin), the ratio between the DMR/SMR (to compensate for possible intersubject variability), and pupillary diameter. Results: Most treated patients were on tamsulosin (27/29). Mean age was similar in study and control groups (70.6±7.6 vs 67.1±9.1 years; P = 0.061). Photopic pupil diameter was reduced in the study group (2.06±0.5 vs 2.5±0.6 mm; P = 0.001). The SMR was similar between groups (P = 0.53). Significantly lower values were found in treated subjects for the DMR and the DMR/SMR ratio (P<0.001). These differences remained significant after adjusting for pupil diameter (P<0.001). Multiple regression analysis showed that a longer duration of α-1ARA treatment correlated to a reduced DMR/SMR ratio (P = 0.001; r = 0.47). Age and eye color were not significant in this model. Conclusions: Patients using systemic α-1ARA have significantly lower values of DMR thickness and DMR/SMR ratio and smaller pupil diameter when compared with age-matched controls. These differences seem to be related to the duration of drug exposure and provide evidence of structural alterations to the iris dilator muscle from this class of agents in IFIS. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.

Original languageEnglish
Pages (from-to)877-881
Number of pages5
JournalOphthalmology
Volume116
Issue number5
DOIs
StatePublished - May 2009
Externally publishedYes

Fingerprint

Dive into the research topics of 'Iris Morphologic Changes Related to α1-Adrenergic Receptor Antagonists. Implications for Intraoperative Floppy Iris Syndrome'. Together they form a unique fingerprint.

Cite this